Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Tumour response · people with advanced gastric cancer

Irinotecan showed no clear difference in tumour response ‐ Substitutive comparisons compared with non‐irinotecan‐containing regimens (low certainty).

1 finding from 1 review

Chemotherapy for advanced gastric cancer 2017 · Cochrane Headline outcomes only
OR 1.53 [0.93, 2.5]
6 studies · 756 participants
Low